News & Updates
Filter by Specialty:
Enhanced liver fibrosis score stratifies HCC risk in CHB patients after HBsAg seroclearance
Researchers at the University of Hong Kong (HKU) have identified enhanced liver fibrosis (ELF) score as a tool to stratify hepatocellular carcinoma (HCC) risk in chronic hepatitis B (CHB) patients after HBsAg seroclearance (SC).
Enhanced liver fibrosis score stratifies HCC risk in CHB patients after HBsAg seroclearance
30 Aug 2022
Obese, postmenopausal women on proinflammatory diet at highest risk of breast cancer
A recent meta-analysis has confirmed the association of a proinflammatory diet with an increased risk of breast cancer, particularly among women who are obese, postmenopausal, and living in developing countries.
Obese, postmenopausal women on proinflammatory diet at highest risk of breast cancer
29 Aug 2022
Adjuvant sorafenib after RFA boosts survival in recurrent hepatocellular carcinoma
The use of sorafenib as an adjuvant therapy after radiofrequency ablation (RFA) appears to improve survival outcomes in patients with recurrent hepatocellular carcinoma who underwent hepatectomy, according to a study.
Adjuvant sorafenib after RFA boosts survival in recurrent hepatocellular carcinoma
27 Aug 2022
Relugolix leads to rapid, sustained profound testosterone suppression in advanced PCa
Use of the oral non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist relugolix led to faster and greater sustained profound testosterone suppression than leuprolide in men with advanced prostate cancer, according to results of the phase III HERO study presented at EAU 2022.
